None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. ASA I & II patients undergoing infraumbilical surgery
Exclusion criteria
Exclusion criteria: 1. Known allergy or hypersensitivity to morphine, ropivacaine, or any local anaesthetic. 2. Infection at the caudal injection site or systemic infection. 3. Bleeding disorders or patients on anticoagulant 4. Chronic respiratory diseases (e.g., severe asthma, obstructive sleep apnea, or any condition predisposing to respiratory depression). 5. Congenital or acquired spinal abnormalities.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the common incidence of side effects, including post operative nausea vomiting (PONV) and urinary retention between the two dosing groupsTimepoint: post op 2hourly assessment will be done for 24hours. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Time to first rescue analgesia, defined as the time from completion of surgery to the first requirement for additional pain medication. 2. Intraoperative and postoperative haemodynamic variation assessment. 3. Postoperative analgesia will be managed according to protocol. Pain will be assessed using the FLACC scale every two hours, with interventions implemented for scores exceeding four. 4. Sedation level will be assessed using the Ramsay Sedation Scale. Timepoint: We will continuously monitor vital parameters (heart rate, blood pressure, oxygen saturation, and respiratory rate) at baseline, preinduction, and post-induction. We will monitor vital signs every 10 minutes during the operation. Postoperatively, we will assess FLACC and Ramsay sedation scores every 15 minutes for the first two hours, then every two hours for up to 24 hours. Postoperatively, we will assess FLACC and Ramsay sedation scores every 15 minutes for the first two hours, then every two hours for up to 24 hours. | — |
Countries
India
Contacts
ARMED FORCES MEDICAL COLLEGE, PUNE